Literature DB >> 2793263

Cortisol level predicts myocardial infarction in patients with ischaemic chest pain.

R J Bain1, V J Poeppinghaus, G M Jones, M J Peaston.   

Abstract

Serum cortisol levels were studied in twenty patients with confirmed myocardial infarction and in twenty patients with severe chest pain admitted to the coronary care unit with suspected myocardial infarction but in whom a diagnosis of angina was subsequently made. Cortisol levels were significantly elevated in patients within five hours of the onset of symptoms in myocardial infarction (857 +/- 74 nmol/l; mean +/- SE) but remained within the normal range for those with angina (340 +/- 55 nmol/l). It is concluded that hypercortisolaemia accompanies myocardial infarction, but not angina, and that the psychological stresses of ischaemic chest pain and admission to the coronary care unit produce little, if any, elevation in serum cortisol levels unless there is significant myocardial necrosis. This observation may be of value to those conducting intervention studies in myocardial infarction since the early elevation of the cortisol levels to above the normal range in patients with ischaemic chest pain is both sensitive (70%) and specific (85%) for myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793263     DOI: 10.1016/0167-5273(89)90164-2

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Lower mean corpuscular hemoglobin concentration is associated with poorer outcomes in intensive care unit admitted patients with acute myocardial infarction.

Authors:  Yuan-Lan Huang; Zhi-De Hu
Journal:  Ann Transl Med       Date:  2016-05

2.  [Altered function of the hypothalamic-pituitary-adrenal axis in patients with acute, chronic and episodic pain].

Authors:  M Strittmatter; O Bianchi; D Ostertag; M Grauer; C Paulus; C Fischer; S Meyer
Journal:  Schmerz       Date:  2005-04       Impact factor: 1.107

3.  Hypothalamo-pituitary-adrenal axis in acute myocardial infarction treated by percutaneous transluminal coronary angioplasty: effect of time of presentation.

Authors:  F Paganelli; C Frachebois; J G Velut; S Boullu; N Sauze; J P Rosso; P Barnay; P Sbragia; R Gelisse; M Grino; S Levy; C Oliver
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

4.  Prognostic Value of Eosinophil to Leukocyte Ratio in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Takao Konishi; Naohiro Funayama; Tadashi Yamamoto; Toru Morita; Daisuke Hotta; Hiroshi Nishihara; Shinya Tanaka
Journal:  J Atheroscler Thromb       Date:  2016-12-01       Impact factor: 4.928

5.  Identification of a plasma metabolomic signature of thrombotic myocardial infarction that is distinct from non-thrombotic myocardial infarction and stable coronary artery disease.

Authors:  Andrew P DeFilippis; Patrick J Trainor; Bradford G Hill; Alok R Amraotkar; Shesh N Rai; Glenn A Hirsch; Eric C Rouchka; Aruni Bhatnagar
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

6.  Prognostic Value of Cortisol Index of Endobiogeny in Acute Myocardial Infarction Patients.

Authors:  Rima Braukyliene; Kamyar Hedayat; Laura Zajanckauskiene; Martynas Jurenas; Ramunas Unikas; Ali Aldujeli; Osvaldas Petrokas; Vytautas Zabiela; Rasa Steponaviciute; Astra Vitkauskiene; Brigita Hedayat; Sandrita Simonyte; Vaiva Lesauskaite; Jean Claude Lapraz; Diana Zaliaduonyte
Journal:  Medicina (Kaunas)       Date:  2021-06-11       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.